We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Recommends Approval for ADHD Patch
FDA Panel Recommends Approval for ADHD Patch
December 9, 2005
An FDA advisory committee voted Dec. 2 to recommend approval for an investigational drug patch to treat attention-deficit/hyperactivity disorder (ADHD) — a decision that came after an FDA clinical reviewer reversed his stance on the drug.